Key statistics
On Friday, Arecor Therapeutics PLC (6UI:FRA) closed at 0.775, -17.11% below its 52-week high of 0.935, set on Jan 07, 2026.
52-week range
| Open | 0.67 |
|---|---|
| High | 0.775 |
| Low | 0.67 |
| Bid | 0.65 |
| Offer | 1.08 |
| Previous close | 0.775 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 37.76m |
| Free float | 17.90m |
| P/E (TTM) | -- |
| Market cap | 29.26m GBP |
| EPS (TTM) | -0.2208 GBP |
Data delayed at least 15 minutes, as of Feb 06 2026 14:25 GMT.
More ▼
Announcements
- Fireside Panel Discussion on Diabetes sector
- Arecor and Sequel Med Tech to host fireside panel
- Holding(s) in Company
- Holding(s) in Company
- Enhanced IP Coverage: AT278 & Oral Peptide Program
- Directorate Changes
- Interim results for the six months to 30 June 2025
- Co-Development Agreement & Monetisation Deal
- Notice of Interim Results
- Positive FDA Feedback on Phase 2 Study Design
More ▼
